Skip to content
ExpreS2ion Biotechnologies

ExpreS2ion Biotechnologies

We’re Here To Solve Your Biggest Protein Challenges

  • ABOUT
    • Our Business
    • History
    • Group Structure
    • Management Team
    • Board of Directors
    • Scientific Advisory Boards
      • Infectious Diseases
      • Oncology
    • Meet us
    • Careers
  • PIPELINE & PLATFORMS
    • Pipeline
    • ExpreS2™
    • Capsid Virus-Like-Particle (AdaptVac)
    • S2 & Glyco-modified cell lines
    • ExpreS2™ FAQs
  • Research Publications
  • INVESTORS
    • Press Releases
    • Financial Reports
    • Presentations
    • Share Information
    • Events
    • Analyst Reports
    • IPO and Rights Issues
    • Corporate Governance
      • Articles of Association
      • General Meetings
      • Board of Directors
      • Management Team
      • Contact Investor Relations
      • Company Description
  • WEBSHOP
0

Cart

Author: Admin

  • Home
  • Admin

Fuld fokus på terapeutisk vaccine

October 27, 2021October 27, 2021

ExpreS2ion Biotechnologies is featured in a publication by Dansk Biotek today (in Danish). Our CEO, Bent Frandsen, presents one of […]

News

Company presentation

July 1, 2021

Check out ExpreS2ion Biotechnologies in this short video. Making a difference within oncology and infectious diseases – and we are […]

News

Structure of Plasmodium falciparum Rh5–CyRPA–Ripr invasion complex

December 12, 2018May 30, 2019

Plasmodium falciparum causes the severe form of malaria that has high levels of mortality in humans. Blood-stage merozoites of P. falciparuminvade erythrocytes, […]

Publications

Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody

September 20, 2018May 30, 2019

The quest to develop an effective malaria vaccine remains a major priority in the fight against global infectious disease. An […]

Publications

Production, quality control, stability, and potency of cGMP-produced Plasmodium falciparum RH5.1 protein vaccine expressed in Drosophila S2 cells

August 17, 2018May 30, 2019

Plasmodium falciparum reticulocyte-binding protein homolog 5 (PfRH5) is a leading asexual blood-stage vaccine candidate for malaria. In preparation for clinical […]

Publications

ExpreS2ion’s CSO Dr. Wian de Jongh to speak at the ISBiotech 8th Spring Meeting in Norfolk, Virginia, USA – March 5-7

February 28, 2018

ExpreS2ion Biotechnologies will be presenting at the ISBiotech 8th Spring Meeting taking place on March 5-7, 2018 in Norfolk, Virginia, […]

News

Upcoming Webinar: Developing an anti-HER2 breast cancer vaccine using advantageous Drosophila S2 cell protein expression and virus-like -particle display technologies

February 27, 2018

ExpreS2ion Biotechnologies and AdaptVac will be presenting at the free webinar on March 14 at 5PM CET / 4PM GMT […]

News

Media article about ExpreS2ion in Affärstidningen Näringsliv, a journal about Life Science in Greater Copenhagen

February 15, 2018

Expres2ion Biotechnologies is mentioned in the Swedish newspaper Affärstidningen Näringsliv, in the supplement section “Time to Unite – a Greater […]

News

Media article about ExpreS2ion in MedWatch, a Danish business journal about the Life Sciences industry

February 8, 2018February 15, 2018

ExpreS2ion Biotechnologies is the topic of an article (in Danish) in the business journal MedWatch under the headline “ExpreS2ion-direktør efter […]

News

ExpreS2ion Biotechnologies Announces Research License Agreement with the University of Pennsylvania

November 8, 2017

Horsholm, Denmark, November 8, 2017 – Today, ExpreS2ion Biotechnologies ApS (“ExpreS2ion”), a fully owned subsidiary of ExpreS2ion Biotech Holding AB, […]

News

Posts navigation

Older posts

Contact Us
VAT: DK32770487

Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Read more about cookies in our Privacy Policy | Terms & General Conditions | Legal Notice & Disclaimer

Follow Us

Copyright © 2023 ExpreS2ion Biotechnologies All rights reserved. Theme: Flash by ThemeGrill. Powered by WordPress
Get a quote - PFs48/45

Error: Contact form not found.

Referrals - PFs48/45
Give me a call - PFs48/45

Error: Contact form not found.

Referrals - TLR8
Referrals - TLR7
Referrals - Ns2B-Ns3
Referrals - GP
Referrals - EctoG
Referrals - E80
Referrals - CrystG
Give me a call - TLR8

Error: Contact form not found.

Give me a call - TLR7

Error: Contact form not found.

Give me a call - Ns2B-Ns3

Error: Contact form not found.

Give me a call - EctoG

Error: Contact form not found.

Give me a call - E80

Error: Contact form not found.

Give me a call - GP

Error: Contact form not found.

Give me a call - CrystG

Error: Contact form not found.

Get a quote - TLR8

Error: Contact form not found.

Get a quote - TRL7

Error: Contact form not found.

Get a quote - Ns2B-Ns3

Error: Contact form not found.

Get a quote - CrystG

Error: Contact form not found.

Get a quote - E80

Error: Contact form not found.

Get a quote - EctoG

Error: Contact form not found.

Get a quote - GP

Error: Contact form not found.

Get a quote - Ns1

Error: Contact form not found.

Give me a call - Ns1

Error: Contact form not found.

Referrals - Ns1
Referrals - Rh5
Get a quote - Rh5

Error: Contact form not found.

Give me a call - Rh5

Error: Contact form not found.